![]() Diclofenac potassium structure
|
Common Name | Diclofenac potassium | ||
---|---|---|---|---|
CAS Number | 15307-81-0 | Molecular Weight | 334.239 | |
Density | N/A | Boiling Point | 412ºC at 760 mmHg | |
Molecular Formula | C14H10Cl2KNO2 | Melting Point | 156-158ºC | |
MSDS | Chinese USA | Flash Point | 203ºC | |
Symbol |
![]() ![]() GHS07, GHS09 |
Signal Word | Warning |
The advantages and limitations of the analgesics available for control of postoperative pain after a dental procedure.
SAAD Dig. 29 , 70-81, (2013)
|
|
Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.
Eur. J. Pharm. Biopharm. 88(2) , 361-73, (2014) Chitosan (CS)-based thermosensitive solutions that turn into semi-solid hydrogels upon injection at body temperature have increasingly drawn attention over the last decades as an attractive new type of in situ forming depot (ISFD) drug delivery system. Despit... |
|
Cystoid macular edema from cancer-associated retinopathy.
Optom. Vis. Sci. 91(4 Suppl 1) , S66-70, (2014) This article reviews the diagnosis and management of a patient with cancer-associated retinopathy (CAR) secondary to small cell lung cancer who developed a rare presentation of CAR, cystoid macular edema (CME). CAR is a rare cause of unexplained, often rapid,... |
|
Transformation and removal pathways of four common PPCP/EDCs in soil.
Environ. Pollut. 193 , 29-36, (2014) Pharmaceutical and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) enter the soil environment via irrigation with treated wastewater, groundwater recharge, and land application of biosolids. The transformation and fate of PPCP/EDCs in... |
|
Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.
J. Pharmacol. Exp. Ther. 350(2) , 387-402, (2014) Covalent protein modifications by electrophilic acyl glucuronide (AG) metabolites are hypothetical causes of hypersensitivity reactions associated with certain carboxylate drugs. The complex rearrangements and reactivities of drug AG have been defined in grea... |
|
The influence of process variables of preparation of oxycellulose beads on their dissolution profile.
Acta Pol. Pharm. 70(2) , 271-81, (2013) Particles preparation from biodegradable polymers as carriers for the controlled release of drugs has been the focus of many investigations and the subject of a growing field of research in recent years. The aim of this study was to develop and optimize the p... |
|
Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study.
BJOG 120(8) , 948-59, (2013) To investigate the individual effects of ibuprofen, diclofenac, naproxen, and piroxicam on pregnancy outcome.Cohort study.Norwegian population.A total of 90 417 women and singleton child pairs.The Norwegian Mother and Child Cohort Study and Medical Birth Regi... |
|
Degradation of diclofenac by ultrasonic irradiation: kinetic studies and degradation pathways.
Chemosphere 113 , 165-70, (2014) Diclofenac (DCF) is a widely used anti-inflammatory drug found in various water bodies, posing threats to human health. In this research, the effects of ultrasonic irradiation at 585kHz on the degradation of DCF were studied under the air, oxygen, argon, and ... |
|
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.
Ann. Intern. Med. 162(1) , 46-54, (2015) The relative efficacy of available treatments of knee osteoarthritis (OA) must be determined for rational treatment algorithms to be formulated.To examine the efficacy of treatments of primary knee OA using a network meta-analysis design, which estimates rela... |
|
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.
Lancet 382(9894) , 769-79, (2013) The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at... |